Vermed Revenue and Competitors
Estimated Revenue & Valuation
- Vermed's estimated annual revenue is currently $35.1M per year.
- Vermed's estimated revenue per employee is $251,000
Employee Data
- Vermed has 140 Employees.
Vermed Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $352.6M | 878 | 6% | $323.5M | N/A |
#2 | $9.3M | 37 | 12% | N/A | N/A |
#3 | $36.4M | 145 | 2% | N/A | N/A |
#4 | $7M | 28 | 0% | N/A | N/A |
#5 | $1M | 4 | -88% | N/A | N/A |
#6 | $7.5M | 21 | -9% | $6.5M | N/A |
#7 | $6M | 24 | 4% | N/A | N/A |
#8 | $13.1M | 52 | 4% | N/A | N/A |
#9 | $17.1M | 68 | -17% | N/A | N/A |
#10 | $27.9M | 111 | 4% | N/A | N/A |
What Is Vermed?
Vermed manufactures high quality EKG electrodes for use in all cardiac monitoring and diagnostic procedures, including stress test, holter test, resting ekg, cardiac rehab, and cath lab. Vermed electrodes are changing the pace of hospital care through enduring innovation. With cost and performance in mind our electrodes are rapidly becoming a vital component in every hospital department. From ClearScan™ technology for accuracy in the Cath Lab to SofTouch™ electrodes for everyday patient comfort and care - welcome to the Vermed Experience.
keywords:N/A
N/A
Total Funding
140
Number of Employees
$35.1M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Vermed News
Vermed; Medtronic; CareFusion; 3M Healthcare; Amhu; Medline Industries; Bio-Protech Products; B Braun Medical; Digitimer; Mega Electronics...
PDC Healthcare; Vermed; Fairmont Medical; Protek Medical Products; Ecolab; CIVCO Medical Solutions; Parker Laboratories Inc. Ultrasonic Probe...
Some of the Top companies Influencing in this Market include:Cardinal Health, 3M, Vermed, QuickMedical, Skintact, ACE Surgical Supply Co.,...
Other Companies in Buffalo
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $38.8M | 141 | 12% | N/A |
#2 | $75M | 141 | 4% | N/A |
#3 | $42.5M | 143 | 11% | N/A |
#4 | $22.3M | 144 | 5% | N/A |
#5 | $23M | 144 | 4% | N/A |